Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 279

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 16
Chunk 279
---
 the fair value measurement of the warrant liability, as follows:

–Evaluated management’s selection of the Black-Scholes model and Monte Carlo model to determine the fair value measurements of the warrant liability.

–Evaluated the incorporation of the applicable estimates and assumptions into the Black-Scholes model and risk-free interest rate as well as testing the model’s mathematical accuracy.

–Tested the underlying source information used by management in making the estimates and assumptions, including the selection of the comparable public companies used in the expected volatility of the common stock.

–Developed an independent estimate and compared our estimate to that used by management.

•We evaluated the presentation of the warrants in the financial statements and the related fair value measurement disclosure.

/s/ Deloitte & Touche LLP

Baltimore, Maryland

March 19, 2025

We have served as the Company’s auditor since 2019.

F-4

Precigen, Inc. and Subsidiaries

Consolidated Balance Sheets

December 31, 2024, and 2023 

(Amounts in thousands, except share data)20242023AssetsCurrent assetsCash and cash equivalents$29,517 $7,578 Short-term investments68,393 55,277 ReceivablesTrade, less allowance for credit losses of $0 and $184 as of December 31, 2024 and 2023, respectively. 926 902 Other237 673 Prepaid expenses and other3,341 4,325 Total current assets102,414 68,755 Property, plant and equipment, net13,831 7,111 Intangible assets, net4,455 40,701 Goodwill19,139 26,612 Right-of-use assets5,056 7,097 Other assets371 767 Total assets$145,266 $151,043 

The accompanying notes are an integral part of these consolidated financial statements.

F-5

Precigen, Inc. and Subsidiaries

Consolidated Balance Sheets

December 31, 2024 and 2023 

(Amounts in thousands, except share data)20242023Liabilities, Mezzanine Equity and Shareholders' EquityCurrent liabilitiesAccounts payable$3,531 $1,726 Accrued compensation and benefits8,417 8,250 Other accrued liabilities4,812 6,223 Indemnification accrual3,213 5